Welcome to Biotech Showcase Digital 2021
Please enjoy the live recordings of these free panel sessions.
Part 1–The world according to COVID-19: From crisis to long-term impact
- Leah Rosenbaum – Assistant Editor, Healthcare & Science, Forbes
- Jeremy Levin – CEO, Ovid Therapeutics; Board of Directors Chair, Biotechnology Innovation Organization (BIO)
- Michelle McMurry-Heath – President and CEO, Biotechnology Innovation Organization (BIO)
The path forward
- Sara Jane Demy - CEO and Founder, Demy-Colton
- Rick Bright - Former Director, Biomedical Advanced Research and Development Authority (BARDA), Transition Team, COVID-19 Advisory Board
By registering you can join the full conference, including 25+ panels and over 350 public and private company presentations. To date over 2,200 delegates are in attendance, including over 750 global investors.
COVID-19 therapeutics: A review of the options
- Stephen G. Brozak, Managing Partner and President, WBB Securities LLC
- Prabhavathi Fernandes,Chair, National Biodefense Science Board
- Michael Kurilla, Director of Division of Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health
In the Balance the humanitarian perspective
- Jeremy Abbate, Publisher, Scientific American
- Ruxandra Draghia-Akli, Global Head, Johnson & Johnson Global Public Health R&D
- Amy Finan, CEO, Sabin Vaccine Institute
- Richard Hatchett, CEO, CEPI